Startseite>>(Rac)-Tavapadon

(Rac)-Tavapadon (Synonyms: (Rac)-PF-06649751; (Rac)-CVL-751)

Katalog-Nr.GC60003

(Rac)-Tavapadon ((Rac)-PF-06649751) ist ein potenter und selektiver Nichtcatechol-Dopamin-D1-Rezeptoragonist.

Products are for research use only. Not for human use. We do not sell to patients.

(Rac)-Tavapadon Chemische Struktur

Cas No.: 1643462-64-9

Größe Preis Lagerbestand Menge
10mM (in 1mL DMSO)
153,00 $
Auf Lager
5mg
139,00 $
Auf Lager
10mg
232,00 $
Auf Lager
50mg
630,00 $
Auf Lager
100mg
973,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

(Rac)-Tavapadon ((Rac)-PF-06649751; (Rac)-CVL-751) is a potent and selective noncatechol dopamine D1 receptor agonist. (Rac)-Tavapadon displays potent full agonism in the GS activation assay as well as partial agonism in the β-arrestin2 recruitment assay (GS-cAMP, EC50=0.8 nM; β-arrestin2, EC50=68 nM). (Rac)-Tavapadon has antiparkinsonian activity[1].

(Rac)-Tavapadon ((Rac)-PF-06649751; (Rac)-CVL-751; compound 32) has EMAXs of 118% and 30% in the GS activation assay and the β-arrestin2 recruitment assay[1].

[1]. Michael L Martini, et al. Designing Functionally Selective Noncatechol Dopamine D 1 Receptor Agonists with Potent In Vivo Antiparkinsonian Activity. ACS Chem Neurosci. 2019 Sep 18;10(9):4160-4182.

Bewertungen

Review for (Rac)-Tavapadon

Average Rating: 5 ★★★★★ (Based on Reviews and 29 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (Rac)-Tavapadon

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.